| Dr Lyn P Chapman, MD | |
|
8500 Edinbrook Pkwy, Brooklyn Park, MN 55443-3720 | |
| (763) 425-1211 | |
| (763) 425-6277 |
| Full Name | Dr Lyn P Chapman |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 8500 Edinbrook Pkwy, Brooklyn Park, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437126158 | NPI | - | NPPES |
| 781195100 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 41482 (Minnesota) | Primary |
| Entity Name | Children's Clinic Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447529235 PECOS PAC ID: 5890949192 Enrollment ID: O20130214000538 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the presentation of updated clinical data from its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin®) in patients with resistant, metastatic breast cancer.
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lyn P Chapman, MD 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443-3720 Ph: (763) 425-1211 | Dr Lyn P Chapman, MD 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443-3720 Ph: (763) 425-1211 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the presentation of updated clinical data from its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin®) in patients with resistant, metastatic breast cancer.
New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
› Verified 6 days ago
Hyder Mohammad Khan, PH.D., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7650 Zane Ave N, Brooklyn Park, MN 55443 Phone: 612-873-6963 | |
Bethany Leigh Templen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10000 Zane Ave N, Brooklyn Park, MN 55443 Phone: 763-569-6293 Fax: 763-569-6258 | |
Dr. Karen A. Arrett, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443 Phone: 763-425-1211 Fax: 763-425-6277 | |
Dr. James R. Bukstein, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443 Phone: 763-425-1211 Fax: 763-425-6277 | |
Dr. Trudie R. Sprenkle, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443 Phone: 763-425-1211 Fax: 763-425-6277 | |
Dr. Jane M. Laco, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8500 Edinbrook Pkwy, Brooklyn Park, MN 55443 Phone: 763-425-1211 Fax: 763-425-6277 |